Bausch Health Companies Inc.'s (BHC) reported second-quarter adjusted earnings per share of 89 cents, on par with the Zacks Consensus Estimate. The reported figure increased from 81 cents in the year-ago quarter due to higher revenues. Total revenues of $2.4 billion were up 11% year over year. The top line also beat the Zacks Consensus Estimate of $2.3 billion. Excluding the impact of foreign exchange of $25 million, acquisitions of $104 million, and divestitures and discontinuations of $14 million, revenue ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State or ot ...

Bausch Health Companies (NYSE:BHC) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Thomas Appio - Chief Executive Officer John Barresi - Interim Chief Financial Officer Garen Sarafian - Investor Relations Conference Call Participants Glen Santangelo - Jefferies Mike Nedelcovych - TD Cowen Jason Gerberry - Bank of America Umer Raffat - Evercore ISI Leszek Sulewski - Truist Securities David Amsellem - Piper Sandler Michael Freeman - Raymond James Operator Greetings! Welcome to ...

Bausch Health (BHC) reported $2.4 billion in revenue for the quarter ended June 2024, representing a yearover-year increase of 10.9%. EPS of $0.98 for the same period compares to $0.81 a year ago. The reported revenue represents a surprise of +2.97% over the Zacks Consensus Estimate of $2.33 billion. With the consensus EPS estimate being $0.89, the EPS surprise was +10.11%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...

Bausch Health (BHC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.81 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10.11%. A quarter ago, it was expected that this drugmaker would post earnings of $0.75 per share when it actually produced earnings of $0.59, delivering a surprise of -21.33%. Over the last four quarters, the compan ...

1 BAUSCH-Health 2 Q 2024 EARNINGS AUGUST 1, 2024 Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements relating to Bausch Health Companies Inc.'s ("Bausch Health" or the "Company") future prospects and performance, financial guidance, research and development efforts and anticipated timing or results thereof, proposed plan to sep ...

Exhibit 99.1 1 CH-Health | --- | --- | |---------------------|----------------------| | | | | Investor Contact: | | | | | | Garen Sarafian | | | ir@bauschhealth.com | | | (877) | 281-6642 (toll free) | | --- | --- | |-------------------------------------------|-------| | | | | Media Contact: | | | Katie Savastano | | | corporate.communications@bauschhealth.com | | | (908) 541-3785 | | BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2024 RESULTS • Second quarter consolidated revenues of $2.40 billion, up 11% on a Rep ...

Bausch Health Companies Overview Harvard Zhang, a Deputy Managing Editor of Reorg.com, posted at 10:26 a.m. on July 24 that "Bausch Health is negotiating a potential prepackaged chapter 11 bankruptcy filing." In the early afternoon, Bausch Health responded to the misleading post. The firm said that the article contained unsubstantiated rumors that included considering a bankruptcy or insolvency proceeding. BHC investors should not expect the firm would sue the reorg site for the posting. Bausch wrote, "We u ...

FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8 (Address of Principal Executive Offices) (Zip Code) Title of each class Trading Symbol(s) Name o ...

Bausch Health Companies [BHC] Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Operator Before we begin, IÂ'd like to remind you that our presentation today contains forward-looking information. We ask you to take a moment to read the forward-looking statements disclaimer at the beginning of the Slides that accompany this presentation, as it contains important information. Our actual results may vary materially from those expressed or implied in our forward-looking statements, and you should not plac ...